Jiangsu Hengrui Pharmaceuticals revenue and financials
In the fiscal year ended December 2025, Jiangsu Hengrui Pharmaceuticals reported revenue of ¥31.63B (+13.02% year over year). Net income was ¥7.71B, a net margin of 24.4%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +13.02%
- 2025 vs 2024
- Net income growth
- +21.69%
- 2025 vs 2024
- Net margin
- 24.4%
- 2024: 22.6%
How Jiangsu Hengrui Pharmaceuticals is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 2.7% a year on average over the last 5 years
Compound annual growth rate: from ¥27.73B in 2020 to ¥31.63B in 2025.
Revenue has grown for 3 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 14.4% to 25.6%
Operating income over revenue, 2022 → 2025: 11.2 percentage points.
Profits turn into cash: free cash flow equal to 108% of net income
Totals for fiscal years 2023–2025: free cash flow ¥19.89B, net income ¥18.35B.
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 31,629 | 27,985 | 22,820 | 21,275 | 25,906 | 27,735 | 23,289 | 17,418 | 13,836 | 11,094 |
| Cost of revenue | 4,450 | 3,881 | 3,562 | 3,503 | 3,756 | 3,356 | 2,918 | 2,338 | 1,851 | 1,433 |
| Gross profit | 27,180 | 24,104 | 19,257 | 17,772 | 22,150 | 24,379 | 20,370 | 15,080 | 11,984 | 9,661 |
| Selling, general and administrative | 11,932 | 10,863 | 9,978 | 9,680 | 12,240 | 12,879 | 10,784 | 8,113 | 6,396 | 6,615 |
| Research and development | 6,961 | 6,583 | 4,954 | 4,887 | 5,943 | 4,989 | 3,896 | 2,670 | 1,759 | — |
| Operating income | 8,086 | 6,476 | 4,176 | 3,060 | 3,765 | 6,272 | 5,501 | 4,060 | 3,575 | 2,844 |
| EBIT | 8,086 | 6,476 | 4,176 | 3,060 | 3,765 | 6,272 | 5,501 | 4,060 | 3,575 | 2,844 |
| EBITDA | 8,889 | 7,198 | 4,843 | 3,599 | 4,260 | 6,720 | 6,120 | 4,439 | 3,893 | 3,098 |
| Interest expense | 14.3 | 5.6 | 5.9 | 6.5 | 4.7 | — | — | — | — | — |
| Pre-tax income | 8,708 | 7,170 | 4,667 | 3,968 | 4,466 | 6,895 | 6,056 | 4,499 | 3,759 | 3,013 |
| Income tax | 991 | 833 | 389 | 153 | -17.7 | 587 | 729 | 438 | 466 | 379 |
| Net income | 7,711 | 6,337 | 4,302 | 3,906 | 4,530 | 6,328 | 5,328 | 4,066 | 3,217 | 2,589 |
| Net income to common shareholders | 7,711 | 6,337 | 4,302 | 3,906 | 4,530 | 6,328 | 5,328 | 4,066 | 3,217 | 2,589 |
| Basic EPS | 1.19 | 1.00 | 0.68 | 0.61 | 0.71 | 0.99 | 0.83 | 0.64 | 0.50 | 0.41 |
| Diluted EPS | 1.18 | 1.00 | 0.68 | 0.61 | 0.71 | 0.99 | 0.83 | 0.64 | 0.50 | 0.41 |
| Average shares (basic) | 6,480 | 6,337 | 6,327 | 6,404 | 6,381 | 6,392 | 6,394 | 6,363 | 6,389 | 6,333 |
| Average shares (diluted) | 6,535 | 6,337 | 6,327 | 6,404 | 6,381 | 6,392 | 6,394 | 6,363 | 6,389 | 6,339 |
| Dividend per share | 0.20 | 0.20 | 0.20 | 0.16 | 0.16 | 0.17 | 0.16 | 0.13 | 0.06 | 0.05 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8,953 | 7,315 | 8,141 | 8,441 | 7,427 | 8,556 | 7,206 | 7,795 | 6,589 | 7,603 | 5,998 | 5,806 |
| Cost of revenue | 1,112 | 1,022 | 1,091 | 1,254 | 1,071 | 1,046 | 1,069 | 1,048 | 976 | 915 | 943 | 905 |
| Gross profit | 7,841 | 6,293 | 7,050 | 7,187 | 6,356 | 7,509 | 6,137 | 6,748 | 5,613 | 6,689 | 5,055 | 4,901 |
| Selling, general and administrative | 5,311 | 2,784 | 2,814 | 3,005 | 3,233 | 3,121 | 2,553 | 2,908 | 2,871 | 2,772 | 2,341 | 2,910 |
| Research and development | 1,930 | 1,842 | 1,651 | 2,016 | 1,717 | 1,695 | 1,533 | 2,034 | 1,511 | 1,818 | 1,220 | 1,228 |
| Operating income | 2,932 | 1,681 | 2,570 | 1,841 | 1,596 | 2,800 | 2,026 | 1,568 | 1,293 | 2,137 | 1,478 | 551 |
| EBIT | 2,777 | 1,681 | 2,570 | 1,841 | 1,596 | 2,800 | 2,026 | 1,568 | 1,293 | 2,137 | 1,478 | 551 |
| EBITDA | 2,777 | 1,925 | 2,771 | 2,041 | 1,776 | 2,998 | 2,206 | 1,748 | 1,459 | 2,308 | 1,644 | 717 |
| Interest expense | 1.0 | 323 | 0.4 | 2.0 | 0.7 | 77.1 | 10.9 | 2.2 | 0.0 | 3.3 | — | 1.2 |
| Pre-tax income | 2,776 | 2,396 | 2,557 | 2,296 | 1,361 | 2,975 | 2,076 | 2,083 | 1,335 | 2,249 | 1,503 | 855 |
| Income tax | 318 | 211 | 276 | 339 | 55.5 | 397 | 199 | 362 | 147 | 188 | 135 | 27.9 |
| Net income | 2,458 | 2,183 | 2,282 | 1,960 | 1,301 | 2,576 | 1,874 | 1,717 | 1,188 | 2,063 | 1,369 | 829 |
| Net income to common shareholders | 2,458 | 2,183 | 2,282 | 1,960 | 1,301 | 2,576 | 1,874 | 1,717 | 1,188 | 2,063 | 1,369 | 829 |
| Basic EPS | — | 0.34 | 0.34 | 0.30 | 0.20 | 0.40 | 0.30 | 0.27 | 0.19 | 0.33 | 0.21 | 0.13 |
| Diluted EPS | — | 0.34 | 0.34 | 0.29 | 0.20 | 0.40 | 0.30 | 0.27 | 0.19 | 0.33 | 0.21 | 0.13 |
| Average shares (basic) | — | 6,421 | 6,713 | 6,534 | 6,671 | 6,468 | 6,247 | 6,362 | 6,274 | 6,191 | 6,519 | 6,361 |
| Average shares (diluted) | — | 6,421 | 6,713 | 6,753 | 6,671 | 6,468 | 6,247 | 6,362 | 6,274 | 6,191 | 6,519 | 6,361 |
| Dividend per share | — | — | — | 0.20 | — | — | — | 0.20 | — | — | — | 0.20 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 69,867 | 50,136 | 43,785 | 42,371 | 39,266 | 34,730 | 27,556 | 22,361 | 18,039 | 14,330 |
| Current assets | 51,490 | 35,315 | 31,287 | 30,934 | 30,188 | 28,050 | 22,311 | 18,069 | 14,469 | 11,393 |
| Cash and equivalents | 40,955 | 24,816 | 20,746 | 15,111 | 13,631 | 10,805 | 5,044 | 3,890 | 4,267 | 4,912 |
| Short-term investments | 114 | 273 | 99.0 | 2,760 | — | — | — | — | 4,550 | 1,530 |
| Receivables | 5,938 | 6,226 | 6,573 | 8,904 | 7,542 | 8,827 | 6,417 | 5,446 | 4,437 | 3,795 |
| Inventory | 2,878 | 2,417 | 2,314 | 2,451 | 2,403 | 1,778 | 1,607 | 1,031 | 790 | 637 |
| Net property, plant and equipment | 7,908 | 6,928 | 6,629 | 6,676 | 6,276 | 4,585 | 4,075 | 3,686 | 3,079 | 2,474 |
| Other intangible assets | 1,956 | 1,192 | 884 | 520 | 442 | 341 | 350 | 273 | 279 | 285 |
| Long-term investments | 2,030 | 1,732 | 1,451 | 1,508 | 1,001 | 1,502 | 599 | 156 | 118 | 81.0 |
| Current liabilities | 6,369 | 3,634 | 2,554 | 3,639 | 3,402 | 3,772 | 2,473 | 2,494 | 2,050 | 1,365 |
| Accounts payable | 1,995 | 1,517 | 1,334 | 1,493 | 1,920 | 1,151 | 1,289 | 1,402 | 393 | 755 |
| Total debt | 74.2 | 110 | 75.2 | 98.9 | 152 | — | — | — | — | — |
| Total liabilities | 8,070 | 4,045 | 2,751 | 3,958 | 3,694 | 3,943 | 2,619 | 2,563 | 2,096 | 1,456 |
| Total equity (incl. minority) | 61,797 | 46,090 | 41,033 | 38,413 | 35,572 | 30,787 | 24,938 | 19,798 | 15,943 | 12,874 |
| Retained earnings | 43,601 | 37,164 | 32,102 | 28,819 | 25,928 | 23,530 | 19,103 | 15,207 | 12,076 | 9,646 |
| Minority interest | 525 | 570 | 567 | 589 | 569 | 283 | 162 | 69.6 | 575 | 486 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 76,720 | 70,773 | 71,294 | 69,867 | 68,328 | 62,894 | 51,293 | 50,136 | 48,338 | 48,181 | 46,340 | 43,785 |
| Current assets | 54,554 | 49,608 | 52,044 | 51,490 | 51,400 | 46,760 | 35,970 | 35,315 | 34,457 | 34,777 | 33,712 | 31,287 |
| Cash and equivalents | 43,447 | 38,734 | 40,527 | 40,955 | 40,364 | 36,122 | 24,086 | 24,816 | 22,132 | 22,312 | 21,306 | 20,746 |
| Short-term investments | 113 | 107 | 109 | 114 | — | 109 | 110 | — | — | — | — | — |
| Receivables | — | 6,260 | 6,507 | 5,938 | 6,264 | 6,076 | 7,339 | 6,226 | 6,923 | 7,322 | 7,839 | 6,573 |
| Inventory | 3,043 | 2,994 | 2,886 | 2,878 | 2,741 | 2,581 | 2,401 | 2,417 | 2,531 | 2,252 | 2,273 | 2,314 |
| Net property, plant and equipment | 8,769 | 8,455 | 8,128 | 7,908 | 7,435 | 7,231 | 7,085 | 6,928 | 6,689 | 6,634 | 6,574 | 6,629 |
| Other intangible assets | 8,716 | 3,317 | 2,259 | 1,956 | 1,455 | 1,400 | 1,381 | 1,192 | 1,165 | 862 | 872 | 884 |
| Long-term investments | 739 | 3,116 | 2,133 | 2,030 | 1,783 | 1,815 | 1,707 | 1,732 | 1,469 | 1,499 | 1,269 | 1,451 |
| Current liabilities | 6,897 | 4,247 | 5,637 | 6,369 | 7,852 | 3,465 | 3,363 | 3,634 | 3,830 | 4,808 | 3,698 | 2,554 |
| Accounts payable | 2,023 | 2,029 | 2,335 | 1,995 | 2,225 | 2,199 | 1,997 | 1,517 | 1,540 | 1,325 | 1,459 | 1,334 |
| Total debt | 422 | 68.0 | 67.5 | 74.2 | 82.4 | 91.4 | 109 | 110 | 87.6 | 95.0 | 78.4 | — |
| Total liabilities | 9,382 | 5,783 | 7,147 | 8,070 | 8,295 | 3,864 | 3,743 | 4,045 | 4,007 | 4,994 | 3,901 | 2,751 |
| Total equity (incl. minority) | 67,337 | 64,990 | 64,147 | 61,797 | 60,033 | 59,030 | 47,550 | 46,090 | 44,332 | 43,187 | 42,439 | 41,033 |
| Retained earnings | 45,771 | 46,741 | 45,884 | 43,601 | 41,641 | 40,340 | 39,038 | 37,164 | 35,447 | 34,260 | 33,471 | 32,102 |
| Minority interest | 523 | 523 | 521 | 525 | 528 | 565 | 563 | 570 | 564 | 565 | 566 | 567 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 11,235 | 7,423 | 7,644 | 1,265 | 4,219 | 3,432 | 3,817 | 2,774 | 2,547 | 2,593 |
| Depreciation and amortization | 843 | 776 | 705 | 578 | 520 | 448 | 619 | 379 | 317 | 254 |
| Capital expenditure | -2,962 | -1,969 | -1,484 | -1,992 | -1,665 | -554 | -561 | -529 | -380 | -1,111 |
| Investing cash flow | -2,741 | -1,912 | 1,222 | 390 | -546 | 1,798 | -1,945 | -2,856 | -3,376 | -2,650 |
| Financing cash flow | 7,782 | -1,551 | -3,144 | -319 | -998 | 291 | -719 | -368 | 220 | -195 |
| Dividends paid | -1,284 | -1,275 | -1,023 | -1,016 | -1,066 | -1,017 | -811 | -368 | -317 | -196 |
| Share repurchases | -978 | -228 | -827 | -1,066 | -235 | -12.0 | -4.6 | -9.3 | -0.5 | — |
| Debt issued | 1,496 | 800 | 21.1 | 1,260 | — | — | — | — | — | — |
| Debt repaid | -1,544 | -847 | -1,315 | -36.3 | -31.1 | — | — | — | — | -10.0 |
| Effect of exchange rates | -360 | 7.4 | 12.5 | 80.5 | -16.9 | -89.1 | 12.3 | 53.8 | -41.9 | 30.9 |
| Net change in cash | 15,916 | 3,968 | 5,734 | 1,417 | 2,657 | 5,432 | 1,165 | -396 | -651 | -221 |
| Free cash flow | 8,273 | 5,454 | 6,160 | -727 | 2,554 | — | — | — | — | — |
| Levered free cash flow | 5,859 | 4,391 | 4,866 | -2,030 | 1,151 | 2,583 | 9,118 | -5,400 | 2,203 | 556 |
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | 1,201 | 786 | 2,125 | 4,810 | 3,745 | 555 | 2,837 | 1,553 | 1,778 | 1,255 | 3,335 |
| Depreciation and amortization | — | 503 | — | 843 | -415 | 419 | — | 776 | -376 | 376 | — | 705 |
| Capital expenditure | -1,093 | -873 | -705 | -1,247 | -447 | -566 | -702 | -445 | -560 | -404 | -561 | -113 |
| Investing cash flow | -1,003 | -1,101 | -724 | -1,214 | -442 | -553 | -532 | -38.5 | -350 | -773 | -750 | -15.3 |
| Financing cash flow | 153 | -1,404 | -186 | -309 | 51.5 | 8,701 | -661 | -44.1 | -1,368 | -120 | -18.1 | -54.5 |
| Dividends paid | 0.0 | -1,328 | — | -10.1 | 0.0 | -1,274 | — | 0.0 | -1,275 | — | — | -0.2 |
| Share repurchases | — | — | — | -978 | — | -383 | — | -228 | — | -110 | — | -827 |
| Debt issued | 354 | 1,192 | 300 | 1,067 | 428 | — | — | 0.0 | 0.0 | 800 | — | — |
| Debt repaid | 0.0 | -1,193 | -300 | -1,544 | 23.0 | -23.0 | — | -47.4 | 27.4 | -827 | — | -50.4 |
| Effect of exchange rates | -243 | -347 | -350 | -214 | -195 | 18.7 | 29.6 | 28.6 | -15.4 | 12.4 | -18.2 | -7.2 |
| Net change in cash | 5,007 | -1,651 | -473 | 388 | 4,225 | 11,911 | -608 | 2,783 | -181 | 897 | 468 | 3,258 |
| Free cash flow | 4,764 | 328 | 81.6 | 878 | 4,363 | 3,180 | -147 | 2,393 | 993 | 1,375 | 694 | 3,221 |
| Levered free cash flow | — | -234 | -818 | 148 | 3,968 | 2,945 | -1,267 | 2,720 | -1,157 | 2,818 | 9.7 | 3,872 |
Financial statements of similar companies
Companies in the group: same industry, similar size
